This trial will study how different "doses" of psychosocial treatment affect youth with bipolar disorder.
12 Primary · 1 Secondary · Reporting Duration: At the end of study completion (5 years)
3 Treatment Groups
1 of 3
1 of 3
1 of 3
60 Total Participants · 3 Treatment Groups
Primary Treatment: Enhanced Care · No Placebo Group · N/A
Who is running the clinical trial?
Age 13 - 23 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this clinical trial accept participants who are 18 years or older?
"This investigation is targeting adolescents aged between 13 and 23." - Anonymous Online Contributor
What is the size of the population participating in this research?
"Affirmative. Data hosted on clinicaltrials.gov states that this medical study, which was initially posted on November 1st 2021, is actively recruiting patients in need. Around 60 individuals must be enrolled from a single healthcare site." - Anonymous Online Contributor
Could I qualify for inclusion in this experiment?
"This research is accepting 60 individuals aged between 13 and 23 years old who are currently afflicted with manic disorder. In addition to this, the participants must have been receiving care from a CAMH psychiatrist at some point in time for eligibility." - Anonymous Online Contributor
Is recruitment still ongoing for this clinical research?
"Affirmative. The evidence hosted on clinicaltrials.gov confirms that the medical trial commenced recruitment on November 1st 2021 and is still active now, as of December 30th 2021. 60 participants will be required from one site to complete this study." - Anonymous Online Contributor